-
ADMA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
ADMA Biologics (ADMA)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 86.71 mm | 86.71 mm | 86.71 mm | 86.71 mm | 86.71 mm | 86.71 mm |
Cash burn (monthly) | 512.33 k | (no burn) | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 2.06 mm | n/a | n/a | n/a | n/a | n/a |
Cash remaining | 84.65 mm | n/a | n/a | n/a | n/a | n/a |
Runway (months of cash) | 165.2 | n/a | n/a | n/a | n/a | n/a |
13F holders | Current |
---|---|
Total holders | 307 |
Opened positions | 93 |
Closed positions | 38 |
Increased positions | 101 |
Reduced positions | 94 |
13F shares | Current |
---|---|
Total value | 3.98 tn |
Total shares | 217.98 mm |
Total puts | 91.60 k |
Total calls | 917.20 k |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 38.27 mm | $765.01 bn |
Vanguard | 18.12 mm | $362.19 bn |
STT State Street | 13.00 mm | $259.97 bn |
IVZ Invesco | 12.62 mm | $252.27 bn |
MS Morgan Stanley | 8.60 mm | $171.91 bn |
Nuveen Asset Management | 6.58 mm | $131.49 bn |
Geode Capital Management | 5.38 mm | $107.61 bn |
D. E. Shaw & Co. | 5.26 mm | $105.23 bn |
Tiaa Cref Investment Management | 4.96 mm | $26.56 mm |
Teachers Advisors | 4.96 mm | $26.56 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Dec 24 | Grossman Adam S | Common Stock | Payment of exercise | Dispose F | No | No | 17.15 | 14,343 | 245.98 k | 1,974,664 |
31 Dec 24 | Kaitlin M. Kestenberg-Messina | Common Stock | Payment of exercise | Dispose F | No | No | 17.15 | 1,854 | 31.80 k | 444,587 |
30 Dec 24 | Eduardo Rene Salas | Stock Option Common Stock | Grant | Acquire A | No | No | 17.49 | 20,011 | 349.99 k | 20,011 |
27 Nov 24 | Steve Elms | Common Stock | Option exercise | Acquire M | Yes | No | 10.8 | 9,000 | 97.20 k | 2,124,671 |
27 Nov 24 | Steve Elms | Stock Option Common Stock | Option exercise | Dispose M | No | No | 10.8 | 9,000 | 97.20 k | 0 |